Correlation Between Vivos Therapeutics and Bausch Lomb

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Bausch Lomb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Bausch Lomb into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Bausch Lomb Corp, you can compare the effects of market volatilities on Vivos Therapeutics and Bausch Lomb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Bausch Lomb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Bausch Lomb.

Diversification Opportunities for Vivos Therapeutics and Bausch Lomb

-0.64

Correlation Coefficient

Vivos Therapeutics  Bausch Lomb

Excellent diversification

The 3 months correlation between Vivos and Bausch is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Bausch Lomb Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Lomb Corp and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Bausch Lomb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Lomb Corp has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Bausch Lomb go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Bausch Lomb

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 3.75 times less return on investment than Bausch Lomb. In addition to that, Vivos Therapeutics is 2.7 times more volatile than Bausch Lomb Corp. It trades about 0.0 of its total potential returns per unit of risk. Bausch Lomb Corp is currently generating about 0.04 per unit of volatility. If you would invest  1,516  in Bausch Lomb Corp on October 9, 2024 and sell it today you would earn a total of  274.00  from holding Bausch Lomb Corp or generate 18.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Bausch Lomb Corp

Vivos Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bausch Lomb Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bausch Lomb Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Bausch Lomb is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Vivos Therapeutics and Bausch Lomb

The main advantage of trading using opposite Vivos Therapeutics and Bausch Lomb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Bausch Lomb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Lomb will offset losses from the drop in Bausch Lomb's long position.

The idea behind Vivos Therapeutics and Bausch Lomb Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.